IL-6 and cfDNA monitoring throughout COVID-19 hospitalization are accurate markers of its outcomes

IL-6 and cfDNA monitoring throughout COVID-19 hospitalization are accurate markers of its outcomes

Abstract Background Severe COVID-19 entails a dysregulated immune response, most likely inflammation related to a lack of virus control. A better understanding of immune toxicity, immunosuppression balance, and COVID-19 assessments could help determine whether different clinical presentations are dr...

Full description

Bibliographic Details
Main Authors: Salvador Bello, Ana Belén Lasierra, Lucía López-Vergara, Cristina de Diego, Laura Torralba, Pablo Ruiz de Gopegui, Raquel Lahoz, Claudia Abadía, Javier Godino, Alberto Cebollada, Beatriz Jimeno, Carlota Bello, Antonio Tejada, Antoni Torres
Format: Article
Language:English
Published: BMC 2023-05-01
Series:Respiratory Research
Subjects:
COVID-19
Cell free DNA
IL-6
Immunity
Longitudinal study
Mortality
Online Access:https://doi.org/10.1186/s12931-023-02426-1

Internet

https://doi.org/10.1186/s12931-023-02426-1

Similar Items